MGRX
Price:
$2.42
Market Cap:
$4.82M
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2023-03-21
Stock Exchange
NASDAQ
Ticker
MGRX
According to Mangoceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -137.99%. This represents a change of 373.11% compared to the average of -29.17% of the last 4 quarters.
The mean historical ROE of Mangoceuticals, Inc. over the last ten years is -469.54%. The current -137.99% ROE has changed -70.61% with respect to the historical average. Over the past ten years (40 quarters), MGRX's ROE was at its highest in in the March 2024 quarter at 247.03%. The ROE was at its lowest in in the December 2023 quarter at -331.47%.
Average
-469.54%
Median
-325.40%
Minimum
-1189.08%
Maximum
105.87%
Discovering the peaks and valleys of Mangoceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 265.42%
Maximum Annual ROE = 105.87%
Minimum Annual Increase = -407.37%
Minimum Annual ROE = -1189.08%
Year | ROE | Change |
---|---|---|
2023 | -1189.08% | 265.42% |
2022 | -325.40% | -407.37% |
The current ROE of Mangoceuticals, Inc. (MGRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-469.54%
5-year avg
-469.54%
10-year avg
-469.54%
Mangoceuticals, Inc.’s ROE is less than FOXO Technologies Inc. (60.45%), greater than ETAO International Co., Ltd. (-1369.49%), less than Healthcare Triangle, Inc. (1.63%), greater than Science 37 Holdings, Inc. (-58.78%), greater than Bullfrog AI Holdings, Inc. Common Stock (-141.38%), less than EUDA Health Holdings Limited (182.22%), greater than Minerva Surgical, Inc. (-67.73%), greater than Aclarion, Inc. (-422.89%), greater than Akili, Inc. (-74.46%), greater than Augmedix, Inc. (-182.36%),
Company | ROE | Market cap |
---|---|---|
60.45% | $5.08M | |
-1369.49% | $9.78M | |
1.63% | $4.53M | |
-58.78% | $34.66M | |
-141.38% | $17.83M | |
182.22% | $173.32M | |
-67.73% | $888.00 | |
-422.89% | $1.20M | |
-74.46% | $34.10M | |
-182.36% | $115.91M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mangoceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mangoceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Mangoceuticals, Inc.'s ROE?
How is the ROE calculated for Mangoceuticals, Inc. (MGRX)?
What is the highest ROE for Mangoceuticals, Inc. (MGRX)?
What is the 3-year average ROE for Mangoceuticals, Inc. (MGRX)?
What is the 5-year average ROE for Mangoceuticals, Inc. (MGRX)?
How does the current ROE for Mangoceuticals, Inc. (MGRX) compare to its historical average?